Scope of the Report:
This report focuses on the Biologic Therapeutics Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The worldwide market for Biologic Therapeutics Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Market Segment by Applications, can be divided into
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
There are 15 Chapters to deeply display the global Biologic Therapeutics Drugs market.
Chapter 1, to describe Biologic Therapeutics Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biologic Therapeutics Drugs, with sales, revenue, and price of Biologic Therapeutics Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologic Therapeutics Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biologic Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biologic Therapeutics Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biologic Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Humans
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Market Analysis by Applications
1.3.1 Rheumatoid Arthritis
1.3.2 Anemia
1.3.3 Cancer
1.3.4 Diabetes
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Biologic Therapeutics Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Biologic Therapeutics Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Biologic Therapeutics Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Biologic Therapeutics Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Smith Medical
2.5.1 Business Overview
2.5.2 Biologic Therapeutics Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Biologic Therapeutics Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Concord Biotech
2.7.1 Business Overview
2.7.2 Biologic Therapeutics Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Aurobindo Pharma
2.8.1 Business Overview
2.8.2 Biologic Therapeutics Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 H. Lundbeck
2.9.1 Business Overview
2.9.2 Biologic Therapeutics Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Retractable Technologies
2.10.1 Business Overview
2.10.2 Biologic Therapeutics Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologic Therapeutics Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Biologic Therapeutics Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologic Therapeutics Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Biologic Therapeutics Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Biologic Therapeutics Drugs Market Analysis by Regions
4.1 Global Biologic Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Biologic Therapeutics Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
4.5 South America Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5 North America Biologic Therapeutics Drugs by Countries
5.1 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Biologic Therapeutics Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Biologic Therapeutics Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6 Europe Biologic Therapeutics Drugs by Countries
6.1 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Biologic Therapeutics Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Biologic Therapeutics Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.3 UK Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.4 France Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Biologic Therapeutics Drugs by Countries
7.1 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biologic Therapeutics Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Biologic Therapeutics Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.5 India Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8 South America Biologic Therapeutics Drugs by Countries
8.1 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Biologic Therapeutics Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Biologic Therapeutics Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Biologic Therapeutics Drugs by Countries
9.1 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biologic Therapeutics Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Biologic Therapeutics Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
10 Global Biologic Therapeutics Drugs Market Segment by Type
10.1 Global Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biologic Therapeutics Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Type (2013-2018)
10.2 Humans Sales Growth and Price
10.2.1 Global Humans Sales Growth (2013-2018)
10.2.2 Global Humans Price (2013-2018)
10.3 Avian Cell Culture Sales Growth and Price
10.3.1 Global Avian Cell Culture Sales Growth (2013-2018)
10.3.2 Global Avian Cell Culture Price (2013-2018)
10.4 Yeast Sales Growth and Price
10.4.1 Global Yeast Sales Growth (2013-2018)
10.4.2 Global Yeast Price (2013-2018)
10.5 Bacteria Sales Growth and Price
10.5.1 Global Bacteria Sales Growth (2013-2018)
10.5.2 Global Bacteria Price (2013-2018)
10.6 Insects Cell Culture Sales Growth and Price
10.6.1 Global Insects Cell Culture Sales Growth (2013-2018)
10.6.2 Global Insects Cell Culture Price (2013-2018)
10.7 Transgenics Sales Growth and Price
10.7.1 Global Transgenics Sales Growth (2013-2018)
10.7.2 Global Transgenics Price (2013-2018)
11 Global Biologic Therapeutics Drugs Market Segment by Application
11.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2013-2018)
11.2 Rheumatoid Arthritis Sales Growth (2013-2018)
11.3 Anemia Sales Growth (2013-2018)
11.4 Cancer Sales Growth (2013-2018)
11.5 Diabetes Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.1 Global Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Biologic Therapeutics Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.2 Europe Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.4 South America Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.3 Biologic Therapeutics Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Biologic Therapeutics Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Biologic Therapeutics Drugs Market Share Forecast by Type (2018-2023)
12.4 Biologic Therapeutics Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Biologic Therapeutics Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Biologic Therapeutics Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biologic Therapeutics Drugs Picture
Table Product Specifications of Biologic Therapeutics Drugs
Figure Global Sales Market Share of Biologic Therapeutics Drugs by Ty